
Chinese pharmaceutical building block and CDMO company headquartered in Nanjing, Jiangsu and listed on the Shenzhen Stock Exchange ChiNext board under code 300725. Designs and supplies novel drug discovery building blocks and scaffolds from a large in-house catalogue, and provides process research, custom synthesis and commercial manufacturing of advanced intermediates and active pharmaceutical ingredients to global pharmaceutical and biotech customers from plants in China and operations in the United States and Europe.
会社プロフィールを見る
評価を残す